
The United States reduced cancer mortality by 26% overall, falling short of the 50% reduction goal set by the American Cancer Society.

The United States reduced cancer mortality by 26% overall, falling short of the 50% reduction goal set by the American Cancer Society.

Sorafenib for advanced hepatocellular carcinoma may not offer the significantly lengthened life expectancy reported in clinical trials.

Nondiscrimination in Health Programs and Activities final rule addresses discrimination and seeks to improve language barriers.

Top news of the day from across the health care landscape.

Most patients with locally advanced non-small cell lung cancer with mediastinal lymph node involvement are generally not considered good candidates for surgery.

Opdivo approved for patients with relapsed or refractory classical Hodgkin lymphoma.

NASP outlines issues with the new proposed rule for Medicare Part B.

Contracts will modify the costs of the cholesterol-lowering drugs Repatha and Praluent based on efficacy in patients.

Imbruvica approved for use in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

Slow-binding inhibitors of cholinesterases could produce treatments for Alzheimer's disease, myasthenia, and neuroprotection.

Researchers found a protective effect against cancer in patients with autism spectrum disorder.

Top news of the day from across the health care landscape.

Diabetes drug interactions may decrease medication efficacy, increase toxicity, challenge adherence, and cause adverse events.

Worm infection in the gut microbiome shows promise reducing the bacterial species linked to a higher risk of IBD.

Lenvatinib with everolimus found to improve progression-free survival in RCC patients.

Personal preference influence pharmacist recommendations for a host of conditions.

Biomarker can help determine the most effective treatment for patients with multiple myeloma.

Dendritic cell-based therapy shows promise treating diabetic peripheral neuropathy and ulcerations in the cornea and skin.

Top news of the day from across the health care landscape.

Subcapsular sinus macrophages may influence cancer mortality.

Antiandrogen therapy plus radiotherapy shows promise reducing prostate cancer mortality.

Borderline personality disorder leads to more risky sexual behavior, increasing the risk of HIV and other sexually transmitted diseases.

Women with HIV are more likely to get pregnant unintentionally.

A high intake of fruit and vegetables in adolescence is linked to a reduced risk of breast cancer, but high alcohol consumption could increase the risk.

Researchers gain greater understanding of genetic and biological basis of diseases such as Alzheimer’s disease, cancer, diabetes, and rheumatoid arthritis.

Top stories of the week on The American Journal of Pharmacy Benefits.

As melatonin levels rise, beta cells are prompted to release less insulin.

Aerosolized SERCA2a gene shown to stop pulmonary hypertension in swine.

Recent advances and updates in oncology and cancer drug development.